Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Feb 02 2022
Business
Feb 2 2022
4 min read

Press Release Feb 02 2022

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 02, 2022, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg".

View Attachment